Arrowstreet Capital, Limited Partnership Innoviva, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Innoviva, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,065,101 shares of INVA stock, worth $19.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,065,101

Previous 404,668 163.2%

Holding current value

$19.6 Million

Previous $6.64 Million 209.72%

% of portfolio

0.02%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.33 - $20.04 $10.8 Million - $13.2 Million	660,433 Added 163.2%	1,065,101 $20.6 Million
Q2 2024 Aug 14, 2024	SELL	$14.4 - $16.4 $854,913 - $973,651	-59,369 Reduced 12.79%	404,668 $6.64 Million
Q1 2024 May 15, 2024	BUY	$14.56 - $16.78 $3.38 Million - $3.89 Million	231,818 Added 99.83%	464,037 $7.07 Million
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $1.41 Million - $1.86 Million	114,504 Added 97.27%	232,219 $3.73 Million
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $800,326 - $898,669	-64,699 Reduced 35.47%	117,715 $1.53 Million
Q2 2023 Aug 14, 2023	BUY	$11.39 - $13.72 $2.08 Million - $2.5 Million	182,414 New	182,414 $2.32 Million
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $1.39 Million - $1.63 Million	118,130 New	118,130 $1.57 Million
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $16.3 Million - $22.7 Million	-1,140,778 Reduced 74.68%	386,829 $5.71 Million
Q1 2022 May 13, 2022	SELL	$15.39 - $20.25 $854,406 - $1.12 Million	-55,517 Reduced 3.51%	1,527,607 $29.6 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $2.61 Million - $3.07 Million	163,996 Added 11.56%	1,583,124 $27.3 Million
Q3 2021 Nov 12, 2021	BUY	$13.06 - $17.24 $9.47 Million - $12.5 Million	725,120 Added 104.48%	1,419,128 $23.7 Million
Q2 2021 Aug 13, 2021	SELL	$11.45 - $13.96 $3.84 Million - $4.68 Million	-334,937 Reduced 32.55%	694,008 $9.31 Million
Q1 2021 May 14, 2021	SELL	$11.06 - $12.87 $5.84 Million - $6.79 Million	-527,700 Reduced 33.9%	1,028,945 $12.3 Million
Q3 2020 Nov 12, 2020	SELL	$10.33 - $14.49 $80,574 - $113,022	-7,800 Reduced 0.5%	1,556,645 $16.3 Million
Q2 2020 Aug 12, 2020	SELL	$11.49 - $15.26 $29,874 - $39,676	-2,600 Reduced 0.17%	1,564,445 $21.9 Million
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $684,167 - $1.28 Million	84,361 Added 5.69%	1,567,045 $18.4 Million
Q4 2019 Feb 13, 2020	BUY	$10.28 - $14.38 $11.3 Million - $15.8 Million	1,098,054 Added 285.48%	1,482,684 $21 Million
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $4.14 Million - $6 Million	-412,215 Reduced 51.73%	384,630 $4.05 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $1.35 Million - $1.54 Million	-103,201 Reduced 11.47%	796,845 $11.6 Million
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $7.51 Million - $11 Million	548,770 Added 156.22%	900,046 $12.6 Million
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $1.74 Million - $2.27 Million	124,384 Added 54.82%	351,276 $6.13 Million
Q3 2018 Nov 14, 2018	SELL	$13.63 - $15.7 $8.45 Million - $9.73 Million	-619,738 Reduced 73.2%	226,892 $3.46 Million
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $7.57 Million - $9.91 Million	563,140 Added 198.65%	846,630 $11.7 Million
Q1 2018 May 14, 2018	BUY	$13.8 - $16.99 $3.91 Million - $4.82 Million	283,490 New	283,490 $4.73 Million
Q4 2017 Feb 09, 2018	SELL	$11.73 - $14.75 $401,166 - $504,450	-34,200 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $412,452 - $482,904	34,200	34,200 $483,000

Others Institutions Holding INVA

# of Institutions

228

Shares Held

79.1M

Call Options Held

37.6K

Put Options Held

300

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.28B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Innoviva, Inc. Transaction History